Recruiting NA Subjective Cognitive Decline (SCD)

New treatment option for Subjective Cognitive Decline (SCD)

Official title Cog-Fun Ageing Participation-centered, Health Promotion for Older Adults

ClinicalTrials.gov ID: NCT06632145

What this study is testing

What it's testing
The goal of this feasibility study is to test the feasibility of a group intervention program based on health management principles for older adults with Subjective Cognitive Decline (SCD). SCD is a condition where individuals feel that their memory is worsening, although standard tests do not detect it.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • Self-reported memory changes,
  • A score of 23 or higher on the Montreal Cognitive Assessment (MoCA)
  • Proficiency in Hebrew to participate fully in a Hebrew-speaking group.

You likely can't join if

  • Presence of a significant health condition that affects functioning
  • Residence in a medical institution or nursing home
  • Current participation in another SCD treatment

The study team makes the final eligibility decision.

Where it's taking place

  • Jerusalem, Israel

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Jerusalem, Israel. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.